1
|
Seol JE, Hong SM, Ahn SW, Kim JU, Cho GJ, Jin WJ, Park SH, Kim H. A Case of Neutrophil-Rich Anaplastic Large-Cell Lymphoma with Relapse. Ann Dermatol 2023; 35:S76-S78. [PMID: 37853871 PMCID: PMC10608385 DOI: 10.5021/ad.21a.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2021] [Revised: 08/30/2021] [Accepted: 09/24/2021] [Indexed: 10/20/2023] Open
Abstract
After anaplastic large-cell lymphoma (ALCL) was first described by Stain in 1985, there have been several histological variants of ALCL reported. There are classified histological subtypes of ALCL, such as lymphohistiocytic, small cell, Hodgkin-like, composite pattern, and other less common variants including neutrophil-rich ALCL. A 63-year-old male patient presented with erythematous exophytic mass on the left lower leg. In the past, his condition had been diagnosed as abdominal primary cutaneous ALCL (pcALCL), which recurred as systemic ALCL (sALCL) in the left bronchus. After treatment, he achieved complete remission. Histopathologic examination showed large-sized pleomorphic, anaplastic mitotic tumor cells, several neutrophils, and a few lymphocytes. Neutrophil-rich ALCL is a rare histological variant of ALCL. It is characterized by the presence of CD30-positive anaplastic tumor cells with numerous neutrophil infiltrations. Neutrophil-rich ALCL responds well to treatment but tends to recur. There were four cases reported to have recurrent neutrophil-rich ALCL. All cases were diagnosed with neutrophil-rich pcALCL prior to recurrence. Three cases had local recurrence, and only one case relapsed as sALCL. Herein, we present the first case of neutrophil-rich ALCL recurring as sALCL twice.
Collapse
Affiliation(s)
- Jung Eun Seol
- Department of Dermatology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
| | - Seong Min Hong
- Department of Dermatology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
| | - Sang Woo Ahn
- Department of Dermatology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
| | - Jong Uk Kim
- Department of Dermatology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
| | - Gyeong Je Cho
- Department of Dermatology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
| | - Woo Jung Jin
- Department of Dermatology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
| | - So Hee Park
- Department of Dermatology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
| | - Hyojin Kim
- Department of Dermatology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
| |
Collapse
|
2
|
Wang DY, Zou LP, Liu XJ, Zhu HG, Zhu R. Chemokine Expression Profiles of Human Hepatoma Cell Lines Mediated by Hepatitis B Virus X Protein. Pathol Oncol Res 2015; 22:393-9. [PMID: 26581611 DOI: 10.1007/s12253-015-0014-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/10/2015] [Accepted: 11/12/2015] [Indexed: 12/31/2022]
Abstract
The hepatitis B virus X protein (HBx), which is encoded by hepatitis B virus (HBV), plays crucial roles in the tumorigenesis of HBV associated hepatocellular carcinoma (HCC). Recent studies suggest that the HBx is involved in regulation of host immune cytokines and chemokines in HBV-associated HCC patients. However, effects of the HBx on autocrine chemokine expression profiles of hepatoma cells, which were shown in modulation of tumor-immune cell interactions, have not been investigated comprehensively. In the present study, human hepatoma cell lines SMMC-7721 and HepG2 were transfected with HBx-expressing plasmid. Human chemokine antibody array 1 (RayBio®), which simultaneously detects 38 chemokine factors, was used to determine chemokine expression profiles. Real-time polymerase chain reaction (real-time PCR) was used to further confirm the differential expression of chemokines. Chemokine antibody array revealed that all 38 chomekines were found to be expressed by SMMC-7721 and HepG2 cell lines. Interleukin-8 (IL-8) was obviously up-regulated, and epithelial neutrophil-activating protein 78 (ENA78), eosinophil chemotactic protein-1 (Eotaxin-1), monocyte chemotactic protein-1 (MCP-1), MCP-2, MCP-3 and macrophage inflammatory protein-3β (MIP-3β) were significantly declined in both cell lines following transfection of HBx-expressing plasmid. Other chemokines showed little or no significant changes. HBx-induced differential chemokine expression levels were validated by real-time PCR. Hierarchical cluster analysis identified a distinction of chomekine expression profiles between HBX-expressing hepatoma cell lines and controls. Our findings provide new evidence that HBx is able to selectively regulate chomekines in hepatoma cells that may be involved in the regulation of tumor-immune cell interactions.
Collapse
Affiliation(s)
- Di-Yi Wang
- Department of Pathology, Affiliated Hospital of Taishan Medical University, Taian, 271000, China.
| | - Li-Ping Zou
- Department of Pathology, Huashan Hospital, Fudan University, Shanghai, 200040, China
| | - Xiao-Jia Liu
- Department of Pathology, Shanghai Medical College, Fudan University, Shanghai, 200032, China
| | - Hong-Guang Zhu
- Department of Pathology, Shanghai Medical College, Fudan University, Shanghai, 200032, China
| | - Rong Zhu
- Department of Pathology, Shanghai Medical College, Fudan University, Shanghai, 200032, China
| |
Collapse
|